Hello and Welcome to Patientsville.com, Your Source for all EMEND information. We are dedicated to provide You with EMEND safety information. Learn about EMEND serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
EMEND Safety Reports
Total EMEND reports: 66.EMEND FDA safety alerts: No.
Reported deaths: 10 Reported hospitalizations: 46.
Take EMEND Side Effects Survey or Share Your EMEND Story. Read More Here.
Physician from UNITED STATES reported EMEND problem on Jan 02, 2007. Female patient, 72 years of age, weighting 141.1 lb, was diagnosed with prophylaxis of nausea and vomiting, neoplasm, thrombosis and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: catheter related infection, international normalised ratio decreased, international normalised ratio increased, tachycardia. EMEND dosage: unknown. During the same period patient was treated with TAXOL, DECADRON, COUMADIN. Patient was hospitalized and became disabled. Patient recovered.
EMEND problem was reported by a Health Professional from FRANCE on Jan 17, 2007. Female patient, 36 years of age, weighting 160.9 lb, was diagnosed with prophylaxis of nausea and vomiting, breast cancer, anxiety and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: dysuria, urinary retention. EMEND dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, PRAZEPAM, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported EMEND problem on Jan 08, 2007. Female patient, 71 years of age, weighting 185.0 lb, was diagnosed with acute myeloid leukaemia and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: angioedema, aspiration, cerebral haemorrhage, cerebral ischaemia, confusional state, diarrhoea, dysphagia, epiglottic oedema, hypersensitivity. EMEND dosage: unknown. During the same period patient was treated with CAP VORINOSTAT, DECITABINE. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Female patient, 71 years of age, weighting 185.0 lb, was diagnosed with acute myeloid leukaemia and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, angioedema, aspiration, cerebral haemorrhage, cerebral ischaemia, cerebrovascular accident, confusional state, convulsion, diarrhoea. EMEND dosage: unknown. During the same period patient was treated with CAP VORINOSTAT, DECITABINE UNK. Patient was hospitalized. Patient died on 01/08/2007.
Physician from GERMANY reported EMEND problem on Feb 02, 2007. Female patient, 44 years of age, weighting 149.9 lb, was diagnosed with anaemia, cervix carcinoma and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: anaemia, cerebral infarction, cerebrovascular accident, gamma-glutamyltransferase increased. EMEND dosage: unknown. During the same period patient was treated with NEORECORMAN, CISPLATIN, NOVALGIN, BLOOD CELLS. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Physician from ISRAEL on Feb 07, 2007. Female patient, 65 years of age, was diagnosed with epilepsy and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: epilepsy. EMEND dosage: unknown. During the same period patient was treated with PHENYTOIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported EMEND problem on Feb 09, 2007. Female patient, 44 years of age, was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: pruritus, urticaria. EMEND dosage: unknown. During the same period patient was treated with NEULASTA. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Health Professional from AUSTRIA on Feb 14, 2007. Female patient, 67 years of age, was diagnosed with prophylaxis of nausea and vomiting, ovarian cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, apnoea, muscle spasms, rash. EMEND dosage: unknown. During the same period patient was treated with CARBOPLATIN AND DOCETAXEL, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported EMEND problem on Feb 02, 2007. Female patient, 71 years of age, weighting 185.0 lb, was diagnosed with acute myeloid leukaemia and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, angioedema, aspiration, cerebral ischaemia, cerebrovascular accident, confusional state, convulsion, diarrhoea, dysphagia. EMEND dosage: unknown. During the same period patient was treated with CAP VORINOSTAT UNK, DECITABINE UNK. Patient was hospitalized. Patient died on 01/08/2007.
EMEND problem was reported by a Physician from UNITED STATES on Feb 16, 2007. Female patient, 44 years of age, was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, urticaria. EMEND dosage: unknown. During the same period patient was treated with NEULASTA. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported EMEND problem on Mar 05, 2007. Female patient, 30 years of age, was diagnosed with procedural nausea and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: hallucination. EMEND dosage: unknown. During the same period patient was treated with PHENERGAN, HALDOL, ZOFRAN. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2007. Male patient, 47 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: neutropenia. EMEND dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Physician from SINGAPORE reported EMEND problem on Mar 22, 2007. Female patient, weighting 158.7 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: convulsion. EMEND dosage: unknown. Patient recovered.
EMEND problem was reported by a Physician from UNITED STATES on Mar 22, 2007. Female patient, 74 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. EMEND dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported EMEND problem on Mar 19, 2007. Male patient, 62 years of age, weighting 189.6 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: catheter site pain, dyspnoea, neutropenia, sepsis. EMEND dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/09/2007.
EMEND problem was reported by a Pharmacist from UNITED STATES on Mar 28, 2007. Male patient, 47 years of age, weighting 134.5 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: neutropenia. EMEND dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported EMEND problem on Mar 29, 2007. Female patient, 44 years of age, weighting 149.9 lb, was diagnosed with prophylaxis of nausea and vomiting, anaemia, cervix carcinoma and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, cervix carcinoma, ischaemic cerebral infarction, malignant neoplasm progression. EMEND dosage: unknown. During the same period patient was treated with NEORECORMAN, CISPLATIN, NOVALGIN, BLOOD CELLS. Patient was hospitalized and became disabled. Patient recovered.
EMEND problem was reported by a Physician from FRANCE on Mar 27, 2007. Female patient, 57 years of age, was diagnosed with prophylaxis of nausea and vomiting, osteosarcoma metastatic and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: encephalopathy. EMEND dosage: unknown. During the same period patient was treated with IFOSFAMIDE, DOXORUBICIN, ONDANSETRON, METHYLPREDNISOLONE, CISPLATIN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported EMEND problem on Apr 04, 2007. Male patient, 14 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: confusional state, neurotoxicity, somnolence. EMEND dosage: unknown. During the same period patient was treated with IFOSFAMIDE, DOXORUBICIN, ONDANSETRON, DECADRON. Patient recovered.
EMEND problem was reported by a Health Professional from UNITED STATES on Apr 05, 2007. Female patient, 74 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. EMEND dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported EMEND problem on Apr 19, 2007. Male patient, 28 years of age, weighting 134.5 lb, was diagnosed with prophylaxis of nausea and vomiting, tongue neoplasm and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: dyspnoea, erythema, hypersensitivity, hypotension. EMEND dosage: unknown. During the same period patient was treated with ONDANSETRON, DOCETAXEL. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Health Professional from FRANCE on Apr 19, 2007. Female patient, 87 years of age, weighting 103.6 lb, was diagnosed with prophylaxis of nausea and vomiting, ovarian cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: erythema, malaise. EMEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ONDANSETRON, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported EMEND problem on May 02, 2007. Male patient, weighting 153.2 lb, was diagnosed with prophylaxis of nausea and vomiting, depression, diabetes mellitus, pancreatic carcinoma metastatic and was treated with EMEND. EMEND dosage: unknown. During the same period patient was treated with ATHYMIL, UMULINE, HUMALOG, FLUOROURACIL, LEUCOVORIN CALCIUM, IRINOTECAN, OXALIPLATIN. Patient died on 03/18/2005.
EMEND problem was reported by a Health Professional from UNITED STATES on May 01, 2007. Female patient, 50 years of age, was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: nephritis haemorrhagic. EMEND dosage: unknown. During the same period patient was treated with HERCEPTIN, TAXOTERE, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported EMEND problem on May 08, 2007. Female patient, 57 years of age, was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: nephritis haemorrhagic. EMEND dosage: unknown. During the same period patient was treated with HERCEPTIN, TAXOTERE, CARBOPLATIN. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Physician from SPAIN on May 11, 2007. Female patient, 71 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: dysphagia, mouth injury, oedema mouth, swelling face. EMEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE. Patient recovered.
Pharmacist from UNITED STATES reported EMEND problem on May 11, 2007. Male patient, 47 years of age, weighting 134.5 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, hyponatraemia, neutropenia. EMEND dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN. Patient recovered.
EMEND problem was reported by a Pharmacist from UNITED STATES on May 11, 2007. Male patient, 62 years of age, weighting 189.6 lb, was diagnosed with prophylaxis of nausea and vomiting, antiemetic supportive care and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: catheter site pain, dyspnoea, neutropenia, sepsis. EMEND dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, DECADRON. Patient was hospitalized. Patient died on 03/09/2007.
Health Professional from FRANCE reported EMEND problem on May 21, 2007. Female patient, 36 years of age, weighting 160.9 lb, was diagnosed with prophylaxis of nausea and vomiting, breast cancer, anxiety and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: dysuria, urinary retention. EMEND dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, PRAZEPAM. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Pharmacist from UNITED STATES on Mar 19, 2007. Male patient, 43 years of age, weighting 189.0 lb, was diagnosed with prophylaxis, testis cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: neutropenia. EMEND dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported EMEND problem on Nov 16, 2006. Male patient, 75 years of age, was diagnosed with prophylaxis and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: asthenia, hiccups, insomnia. EMEND dosage: unknown. During the same period patient was treated with DECADRON, ELOXATIN, FLUOROURACIL. Patient recovered.
EMEND problem was reported by a Physician from UNITED STATES on Oct 05, 2006. Female patient was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia. EMEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized and became disabled. Patient recovered.
Physician from UNITED STATES reported EMEND problem on July 27, 2006. Female patient, 30 years of age, was diagnosed with prophylaxis and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. EMEND dosage: 125 MG/1X/PO. During the same period patient was treated with PLATINOL, ZOFRAN, DEXAMETHASONE PHOSPHATE, FLUOROURACIL. Patient recovered.
EMEND problem was reported by a Health Professional from FRANCE on June 11, 2007. Male patient, 58 years of age, weighting 189.6 lb, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: pancytopenia, pyrexia. EMEND dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, ACETAMINOPHEN, ESOMEPRAZOLE MAGNESIUM, PAROXETINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Physician from SPAIN reported EMEND problem on June 20, 2007. Female patient, 71 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: dysphagia, headache, mouth injury, oedema mouth, swelling face. EMEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE. Patient recovered.
EMEND problem was reported by a Health Professional from FRANCE on May 03, 2006. Male patient, 72 years of age, weighting 189.6 lb, was diagnosed with prophylaxis of nausea and vomiting, colon cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: dizziness, extrasystoles, palpitations. EMEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE, DEXCHLORPHENIRAMINE MALEATE, IRINOTECAN HYDROCHLORIDE, ERBITUX, ATROPINE, ONDANSETRON HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Pharmacist from AUSTRALIA reported EMEND problem on Apr 24, 2006. Male patient, 45 years of age, was diagnosed with prophylaxis of nausea and vomiting, chronic lymphocytic leukaemia and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: headache, hyperacusis, photophobia. EMEND dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Pharmacist from GERMANY on June 16, 2006. Male patient, 66 years of age, weighting 143.3 lb, was diagnosed with prophylaxis of nausea and vomiting, metastatic neoplasm and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: anorexia, apathy, asthenia, dizziness, fatigue, weight decreased. EMEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE PHOSPHATE, DEXAMETHASONE PHOSPHATE, TROPISETRON HYDROCHLORIDE, GEMCITABINE, CISPLATIN. Patient recovered.
Physician from UNITED KINGDOM reported EMEND problem on July 25, 2006. Male patient, child 7 years of age, weighting 50.71 lb, was diagnosed with cyclic vomiting syndrome, prophylaxis and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: palpitations, prescribed overdose, sinus bradycardia, tachycardia. EMEND dosage: unknown. During the same period patient was treated with PROPRANOLOL HYDROCHLORIDE, DEXAMETHASONE, ONDANSETRON, CHLORPROMAZINE. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Health Professional from UNITED STATES on Aug 15, 2006. Female patient, 42 years of age, was diagnosed with nausea and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: abdominal pain, constipation, intestinal perforation. EMEND dosage: unknown. During the same period patient was treated with ANZEMET, DECADRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from UNITED STATES reported EMEND problem on Aug 15, 2006. Female patient, 42 years of age, was diagnosed with nausea and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: constipation, intestinal perforation. EMEND dosage: unknown. During the same period patient was treated with ANZEMET, DECADRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized and became disabled. Patient recovered.
EMEND problem was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Female patient, 50 years of age, was diagnosed with prophylaxis of nausea and vomiting, deep vein thrombosis and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. EMEND dosage: unknown. During the same period patient was treated with COUMADIN, ALOXI, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported EMEND problem on Aug 22, 2006. Female patient, 60 years of age, weighting 154.3 lb, was diagnosed with vomiting, hypertension, malaise, deep vein thrombosis and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dizziness, dyspnoea, muscle spasms, myalgia, tremor. EMEND dosage: unknown. During the same period patient was treated with ATENOLOL, BENDROFLUMETHIAZIDE, DEXAMETHASONE, WARFARIN. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Health Professional from UNITED STATES on Aug 15, 2006. Female patient, 42 years of age, was diagnosed with nausea and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: abdominal pain, constipation, intestinal perforation, peritonitis. EMEND dosage: unknown. During the same period patient was treated with ANZEMET, DECADRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from FRANCE reported EMEND problem on Oct 03, 2006. Female patient, 55 years of age, weighting 110.2 lb, was diagnosed with prophylaxis of nausea and vomiting, biliary neoplasm and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema. EMEND dosage: unknown. During the same period patient was treated with MANNITOL, CISPLATIN, GEMCITABINE, METHYLPREDNISOLONE SUCCINATE, GRANISETRON. Patient recovered.
EMEND problem was reported by a Health Professional from UNITED STATES on Oct 12, 2006. Female patient, 58 years of age, was diagnosed with prophylaxis of nausea and vomiting, colon cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: gastroenteritis, intestinal haemorrhage. EMEND dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported EMEND problem on Aug 17, 2006. Female patient, 54 years of age, weighting 196.2 lb, was diagnosed with prophylaxis of nausea and vomiting, deep vein thrombosis, international normalised ratio, antiemetic supportive care and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. EMEND dosage: unknown. During the same period patient was treated with COUMADIN, ALOXI, DECADRON, CYTOXAN, ADRIAMYCIN PFS. Patient recovered.
EMEND problem was reported by a Physician from GERMANY on Nov 03, 2006. Female patient, 48 years of age, weighting 141.1 lb, was diagnosed with prophylaxis of nausea and vomiting, epilepsy and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: convulsion. EMEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE, GRANISETRON, FLUOROURACIL, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, CARBAMAZEPINE. Patient recovered.
Physician from GERMANY reported EMEND problem on Nov 03, 2006. Female patient, 48 years of age, weighting 141.1 lb, was diagnosed with prophylaxis of nausea and vomiting, epilepsy and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: convulsion. EMEND dosage: unknown. During the same period patient was treated with DEXAMETHASONE, GRANISETRON, FLUOROURACIL, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, CARBAMAZEPINE. Patient recovered.
EMEND problem was reported by a Physician from UNITED STATES on Nov 30, 2006. Female patient was diagnosed with prophylaxis and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: confusional state, convulsion, postictal state. EMEND dosage: 125 MG/1X/PO; SEE IMAGE. During the same period patient was treated with DEXAMETHASONE, PALONOSETRON HYDROCHLORIDE, CYCLOPHOSPHAMIDE, DOXORUBICIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported EMEND problem on Dec 18, 2006. Female patient, 71 years of age, weighting 185.0 lb, was diagnosed with acute myeloid leukaemia and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, diarrhoea, hypersensitivity. EMEND dosage: unknown. During the same period patient was treated with CAP VORINOSTAT UNK, DECITABINE UNK. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Physician from UNITED STATES on Dec 20, 2006. Female patient, 71 years of age, weighting 185.0 lb, was diagnosed with acute myeloid leukaemia and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, diarrhoea, hypersensitivity, pyelonephritis, renal failure, urinary tract infection. EMEND dosage: unknown. During the same period patient was treated with CAP VORINOSTAT UNK, DECITABINE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported EMEND problem on July 13, 2007. Female patient, 47 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, headache, nausea, pharyngolaryngeal pain, tongue blistering, vision blurred, vomiting. EMEND dosage: unknown. During the same period patient was treated with ALOXI, ATIVAN, CYTOXAN, DEXAMETHASONE, DOXORUBICIN. Patient recovered.
EMEND problem was reported by a Health Professional from FRANCE on July 12, 2007. Male patient, 49 years of age, was diagnosed with prophylaxis of nausea and vomiting, synovial sarcoma metastatic and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: neutropenia, thrombocytopenia. EMEND dosage: unknown. During the same period patient was treated with PEGFILGRASTIM, DOXORUBICIN HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, METHYLPREDNISOLONE SUCCINATE, METOCLOPRAMIDE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported EMEND problem on July 12, 2007. Female patient, 36 years of age, was diagnosed with prophylaxis of nausea and vomiting, liposarcoma and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation, palpitations. EMEND dosage: unknown. During the same period patient was treated with PEGFILGRASTIM, DOXORUBICIN HYDROCHLORIDE, IFOSFAMIDE. Patient died on 02/16/2007.
EMEND problem was reported by a Health Professional from FRANCE on July 12, 2007. Female patient, 56 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: leukopenia, neutropenia. EMEND dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported EMEND problem on July 20, 2007. Female patient, 56 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: leukopenia, neutropenia. EMEND dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Health Professional from FRANCE on July 16, 2007. Female patient, 36 years of age, was diagnosed with prophylaxis of nausea and vomiting, liposarcoma and was treated with EMEND. EMEND dosage: unknown. During the same period patient was treated with PEGFILGRASTIM, DOXORUBICIN HYDROCHLORIDE, IFOSFAMIDE. Patient died on 02/16/2007.
Health Professional from FRANCE reported EMEND problem on July 12, 2007. Male patient, 49 years of age, was diagnosed with prophylaxis of nausea and vomiting, synovial sarcoma metastatic and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: neutropenia, thrombocytopenia. EMEND dosage: unknown. During the same period patient was treated with PEGFILGRASTIM, DOXORUBICIN HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, METHYLPREDNISOLONE SUCCINATE, METOCLOPRAMIDE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Health Professional from FRANCE on July 23, 2007. Female patient, 36 years of age, was diagnosed with prophylaxis of nausea and vomiting, liposarcoma and was treated with EMEND. EMEND dosage: unknown. During the same period patient was treated with PEGFILGRASTIM, DOXORUBICIN HYDROCHLORIDE, IFOSFAMIDE. Patient died on 02/16/2007.
Physician from AUSTRALIA reported EMEND problem on Aug 08, 2007. Female patient, 43 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: palmar-plantar erythrodysaesthesia syndrome. EMEND dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Physician from AUSTRALIA on Aug 08, 2007. Female patient, 43 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: palmar-plantar erythrodysaesthesia syndrome. EMEND dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Health Professional from AUSTRALIA reported EMEND problem on Sept 10, 2007. Female patient, 47 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: aphasia, coordination abnormal, paraesthesia, transient ischaemic attack. EMEND dosage: unknown. During the same period patient was treated with ONDANSETRON HYDROCHLORIDE, MORPHINE SULPHATE, PANTOPRAZOLE, DEXAMETHASONE, METOCLOPRAMIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
EMEND problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Male patient, 73 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: hiccups. EMEND dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died.
Health Professional from UNITED STATES reported EMEND problem on Sept 17, 2007. Male patient, 73 years of age, was diagnosed with prophylaxis of nausea and vomiting, lung neoplasm malignant and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: hiccups. EMEND dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died.
EMEND problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2007. Female patient, 55 years of age, was diagnosed with colon cancer and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, calculus ureteric, hydronephrosis, hydroureter, nausea, neutrophil count decreased. EMEND dosage: unknown. During the same period patient was treated with CETUXIMAB, LEUCOVORIN CALCIUM, FLUOROURACIL, OXALIPLATIN, MARINOL, PROTONIX. Patient was hospitalized. Patient recovered.